GeekWire logo

GeekWire

linkedin.com

GeekWire provides technology news, analysis, and resources for tech professionals, entrepreneurs, and enthusiasts. It covers developments in the technology industry, produces events and podcasts, and offers tools such as job boards and startup rankings to support the tech community. Its mission is to inform and connect people interested in technology and startups.

Facts

HQ
Seattle
Sectors
Online Audio and Video Media
Founded
2011
Employees
26
Registered name
GeekWire LLC Seattle business license
Founders
John Cook, Todd Bishop

Is this your organization? Claim it

Publication

  • Last published Oct 15

Authors & Editors

Seattle Biotech Intrinsic Medicine Withdraws $20.3M IPO Filing While Developing Human Milk Molecule Therapies

Seattle biotech Intrinsic Medicine, developing sugar-based molecules found in human milk for immune and gut health disorders, withdrew its IPO filing after planning to raise $20.3 million. The company, founded in 2018 and led by CEO Alex Martinez, is conducting preclinical programs for several conditions and planned a phase 2 trial in Australia for irritable bowel syndrome.

Possible Finance and Lending Club Thrive Amid Rising Interest Rates by Serving Underserved Markets and Leveraging Banking Charters

Some tech-driven lending companies like Possible Finance and Lending Club are benefiting or remaining stable despite rising interest rates, as they cater to underserved or recession-resistant markets and have diversified revenue streams. Possible Finance expects growth fueled by increased demand for consumer credit among lower-income Americans, while Lending Club's banking charter helps buffer economic downturn impacts.

University of Washington Spinout Aquagga Develops Technology to Destroy PFAS 'Forever Chemicals' with No Toxic Byproducts

Aquagga, a Seattle-based cleantech startup founded by University of Washington and Alaska researchers, develops a high-temperature, high-pressure system to completely destroy PFAS 'forever chemicals' in water and soil with no toxic byproducts. The company aims to address EPA concerns about PFAS contamination by providing scalable destruction technology for environmental remediation.

Techstars CEO Maelle Gavet Highlights Economic Downturn Challenges and Startup Support Role Amid $2.5B Raised by Accelerated Firms

Maelle Gavet, CEO of Techstars, warns of a significant market reset in the tech industry due to an economic downturn but highlights Techstars’ role in helping startups build resilient businesses and secure funding. Since launching in 2006, Techstars has accelerated nearly 3,000 startups, with its Seattle program producing over 130 companies that have raised $2.5 billion collectively.

Loopie Laundry Raises Nearly $1 Million from Early Uber Investor Jason Calacanis to Expand Nationally

Loopie Laundry, a peer-to-peer laundry startup founded by John Vincent Lee in 2018, raised nearly $1 million from investor Jason Calacanis and the Launch Syndicate to expand its service across multiple U.S. cities. The company, which has already generated over $2 million in sales and employs 40 people, connects customers needing laundry service with home washers and drivers.

Echodyne Secures $135M Funding Led by Bill Gates and Baillie Gifford to Expand Next-Gen Radar Production

Echodyne, a radar technology company backed by Bill Gates and Baillie Gifford, secured $135 million in funding to expand production of its advanced radar systems used in drones, law enforcement, and infrastructure monitoring. The funding boosts its total investment to $195 million as it prepares to launch its next-generation radar with triple the range of its current product.

Pacific Northwest Life Sciences Update: Talus Bioscience Raises $9.75M, Kineta Merges with Yumanity, UW’s David Baker Launches Charm Therapeutics

Recent Pacific Northwest life sciences news includes Talus Bioscience raising $9.75 million, Kineta going public via merger with Yumanity, and UW's David Baker launching Charm Therapeutics. Key partnerships involve TwinStrand and Singular Genomics developing rare gene variant tests, and Umoja Biopharma partnering with TreeFrog Therapeutics for stem cell therapies.

David Baker Launches London Biotech Charm Therapeutics with $50M Series A to Advance Deep Learning Drug Discovery

David Baker, leader of the University of Washington Institute for Protein Design, co-founded London-based Charm Therapeutics, which uses deep learning to discover new small molecule therapeutics, and recently secured $50 million in Series A funding. The company's DragonFold platform predicts protein-small molecule interactions to aid drug discovery in cancer and other diseases.

People

See all 5

Online